INTERCEPT PHARMACEUTICALS IN - NOTE 3.250% 7/0

Historical Holders from Q2 2016 to Q3 2023

Type / Class
Debt / NOTE 3.250% 7/0
All holders as of 30 Sep 2023
Q3 2023
Total 13F principal, excl. options
0
Holdings value
$0
Number of holders
0
Number of sells
-4
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Institutional Holders of INTERCEPT PHARMACEUTICALS IN - NOTE 3.250% 7/0

Period Principal Value Change Price Investors
2023 Q3 $0 $0 -$10.1M 0
2023 Q2 $9.72M $10.1M -$86.5M $1.00 4
2023 Q1 $96.9M $96.5M +$4.66M $0.99 17
2022 Q4 $92.3M $90.8M +$10.6M $0.98 22
2022 Q3 $77.1M $76.1M +$563K $0.97 19
2022 Q2 $76.6M $75.6M -$18.7M $0.97 19
2022 Q1 $82.9M $90.5M +$3.53M $0.92 23
2021 Q4 $82.8M $79.2M -$6.47K $0.95 24
2021 Q3 $84.1M $77M -$294M $0.90 26
2021 Q2 $411M $370M -$21.1M $0.90 33
2021 Q1 $450M $374M -$3.65M $0.82 41
2020 Q4 $439M $343M -$798K $0.78 35
2020 Q3 $469M $379M +$2.39M $0.80 46
2020 Q2 $445M $334M +$4.65M $0.75 45
2020 Q1 $443M $361M +$7.51M $0.81 49
2019 Q4 $433M $439M +$11.2M $1.01 44
2019 Q3 $429M $370M +$12.1M $0.86 44
2019 Q2 $418M $386M -$39.4M $0.89 48
2019 Q1 $455M $452M +$30.9M $0.99 48
2018 Q4 $425M $390M +$9.16M $0.92 43
2018 Q3 $418M $422M +$54.1M $1.01 44
2018 Q2 $359M $315M -$1.91M $0.88 43
2018 Q1 $364M $292M +$2.56M $0.81 43
2017 Q4 $366M $294M -$19.7M $0.80 45
2017 Q3 $392M $305M -$475K $0.78 49
2017 Q2 $378M $369M +$6.72M $0.98 39
2017 Q1 $372M $348M -$28.8M $0.93 40
2016 Q4 $406M $363M -$11.4M $0.90 43
2016 Q3 $407M $456M +$445M $1.12 43
2016 Q2 $10M $10.3M +$10.3M $1.03 1